{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:43:40Z","timestamp":1794109420271,"version":"4.8.0"},"reference-count":182,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC113\\u20132320-B-037\\u2013011-MY3"],"award-info":[{"award-number":["NSTC113\\u20132320-B-037\\u2013011-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC114\\u20132735-B-001\\u2013001"],"award-info":[{"award-number":["NSTC114\\u20132735-B-001\\u2013001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC113\\u20132314-B-214\\u2013002"],"award-info":[{"award-number":["NSTC113\\u20132314-B-214\\u2013002"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003835","name":"I-Shou University","doi-asserted-by":"publisher","award":["ISU113-S-03"],"award-info":[{"award-number":["ISU113-S-03"]}],"id":[{"id":"10.13039\/501100003835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TB114008"],"award-info":[{"award-number":["KMU-TB114008"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TC114A08"],"award-info":[{"award-number":["KMU-TC114A08"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.biopha.2026.119069","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:11:28Z","timestamp":1772557888000},"page":"119069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Lysophosphatidylcholine as a mechanistic and therapeutic nexus in atherosclerotic cardiovascular disease"],"prefix":"10.1016","volume":"197","author":[{"given":"Ting-Chieh","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Chi","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Chen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Sheng","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal Kedihithlu","family":"Marathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenter","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Yin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biopha.2026.119069_bib1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.clinthera.2023.09.020","article-title":"Global Trends in Atherosclerotic Cardiovascular Disease","volume":"45","author":"Nedkoff","year":"2023","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra035098","article-title":"Cardiovascular disease","volume":"349","author":"Nabel","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2026.119069_bib3","unstructured":"W.H. Federation, World Heart Report 2023: Confronting the World\u2019s Number One Killer, 2023."},{"key":"10.1016\/j.biopha.2026.119069_bib4","unstructured":"Cardiovascular diseases, 2024. \u3008https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/cardiovascular-diseases\u3009. (Accessed 8 Jan 2026)."},{"key":"10.1016\/j.biopha.2026.119069_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176338","article-title":"Hegemony of inflammation in atherosclerosis and coronary artery disease","volume":"966","author":"Attiq","year":"2024","journal-title":"Eur. J. Pharm."},{"issue":"24","key":"10.1016\/j.biopha.2026.119069_bib6","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur. Heart J."},{"issue":"14","key":"10.1016\/j.biopha.2026.119069_bib7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/CIRCULATIONAHA.122.061010","article-title":"Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis: The Western Denmark Heart Registry","volume":"147","author":"Mortensen","year":"2023","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.biopha.2026.119069_bib8","first-page":"e596","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12916-020-01792-7","article-title":"LDL-C: lower is better for longer-even at low risk","volume":"18","author":"Penson","year":"2020","journal-title":"BMC Med"},{"issue":"24","key":"10.1016\/j.biopha.2026.119069_bib10","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15","key":"10.1016\/j.biopha.2026.119069_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023690","article-title":"Association of Low-Density Lipoprotein Cholesterol Levels with More than 20-Year Risk of Cardiovascular and All-Cause Mortality in the General Population","volume":"11","author":"Rong","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2026.119069_bib12","doi-asserted-by":"crossref","first-page":"22111","DOI":"10.1038\/s41598-021-01738-w","article-title":"Association between low density lipoprotein cholesterol and all-cause mortality: results from the NHANES 1999\u20132014","volume":"11","author":"Liu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119069_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pharmthera.2016.11.001","article-title":"Intensive LDL-cholesterol lowering therapy and neurocognitive function","volume":"170","author":"Banach","year":"2017","journal-title":"Pharm. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2026.119069_bib14","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1161\/ATV.0000000000000164","article-title":"Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association","volume":"43","author":"Goldstein","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/clinchem\/hvaa252","article-title":"Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation","volume":"67","author":"Hoogeveen","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.biopha.2026.119069_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1389106","article-title":"Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape-focus on hypertriglyceridaemia","volume":"11","author":"Bashir","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.biopha.2026.119069_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102762","article-title":"Novel oxidized LDL-based clinical markers in peritoneal dialysis patients for atherosclerosis risk assessment","volume":"64","author":"Papadea","year":"2023","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119069_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8080254","article-title":"Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis","volume":"8","author":"Chu","year":"2020","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4196\/kjpp.2009.13.1.27","article-title":"Oxidized Low-density Lipoprotein- and Lysophosphatidylcholine-induced Ca Mobilization in Human Endothelial Cells","volume":"13","author":"Kim","year":"2009","journal-title":"Korean J. Physiol. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib20","first-page":"299","article-title":"Increased lysophosphatidylcholine and non-esterified fatty acid content in LDL induces chemokine release in endothelial cells. Relationship with electronegative LDL","volume":"177","author":"Benitez","year":"2004","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.biopha.2026.119069_bib21","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/art.41213","article-title":"Role of Low-Density Lipoprotein in Early Vascular Aging Associated With Systemic Lupus Erythematosus","volume":"72","author":"Chan","year":"2020","journal-title":"Arthritis Rheuma"},{"issue":"3","key":"10.1016\/j.biopha.2026.119069_bib22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/ATVBAHA.123.319937","article-title":"Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation","volume":"44","author":"Dzobo","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119069_bib23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/hmg\/ddm029","article-title":"Production of lysophosphatidylcholine by cPLA2 in the brain of mice lacking PPT1 is a signal for phagocyte infiltration","volume":"16","author":"Zhang","year":"2007","journal-title":"Hum. Mol. Genet"},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2025.100742","article-title":"Contribution of individual phospholipase A(2) enzymes to the cleavage of oxidized phospholipids in human blood plasma","volume":"66","author":"Jokesch","year":"2025","journal-title":"J. Lipid Res"},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib25","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102953118","article-title":"Lipoprotein-associated phospholipase A(2): A paradigm for allosteric regulation by membranes","volume":"119","author":"Mouchlis","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.biopha.2026.119069_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051149","article-title":"An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases","volume":"20","author":"Law","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2026.119069_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24086956","article-title":"Untargeted Lipidomic Profiling Reveals Lysophosphatidylcholine and Ceramide as Atherosclerotic Risk Factors in apolipoprotein E Knockout Mice","volume":"24","author":"Law","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119069_bib28","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.bbalip.2013.11.013","article-title":"Micromolar changes in lysophosphatidylcholine concentration cause minor effects on mitochondrial permeability but major alterations in function","volume":"1841","author":"Hollie","year":"2014","journal-title":"Biochim Biophys. Acta"},{"issue":"6","key":"10.1016\/j.biopha.2026.119069_bib29","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1194\/jlr.M400464-JLR200","article-title":"Mitochondrial dysfunction induces triglyceride accumulation in 3T3-L1 cells: role of fatty acid beta-oxidation and glucose","volume":"46","author":"Vankoningsloo","year":"2005","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.biopha.2026.119069_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.actbio.2016.10.043","article-title":"Calcium-independent binding of human C-reactive protein to lysophosphatidylcholine in supported planar phospholipid monolayers","volume":"48","author":"Goda","year":"2017","journal-title":"Acta Biomater."},{"issue":"12","key":"10.1016\/j.biopha.2026.119069_bib31","doi-asserted-by":"crossref","first-page":"8560","DOI":"10.4049\/jimmunol.177.12.8560","article-title":"Lysophosphatidylcholine stimulates IL-1beta release from microglia via a P2X7 receptor-independent mechanism","volume":"177","author":"Stock","year":"2006","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020319","article-title":"Nutritional Genomics in Nonalcoholic Fatty Liver Disease","volume":"11","author":"Vasconcellos","year":"2023","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.biopha.2026.119069_bib33","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1194\/jlr.P085050","article-title":"Abnormal liver phosphatidylcholine synthesis revealed in patients with acute respiratory distress syndrome","volume":"59","author":"Dushianthan","year":"2018","journal-title":"J. Lipid Res"},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1194\/jlr.D011916","article-title":"Specificity and rate of human and mouse liver and plasma phosphatidylcholine synthesis analyzed in vivo","volume":"52","author":"Pynn","year":"2011","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.biopha.2026.119069_bib35","series-title":"Phospholipases in Physiology and Pathology","first-page":"111","article-title":"Chapter 7 - Phospholipase-based nanocarriers for therapeutic applications","author":"Sella","year":"2023"},{"key":"10.1016\/j.biopha.2026.119069_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/2058738419827154","article-title":"Lp-PLA(2), a new biomarker of vascular disorders in metabolic diseases","volume":"33","author":"De Stefano","year":"2019","journal-title":"Int J. Immunopathol. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2026.119069_bib37","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.CIR.0000154553.12214.CD","article-title":"Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke","volume":"111","author":"Oei","year":"2005","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.biopha.2026.119069_bib38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11883-022-01023-9","article-title":"More than Just a Monolayer: the Multifaceted Role of Endothelial Cells in the Pathophysiology of Atherosclerosis","volume":"24","author":"Mussbacher","year":"2022","journal-title":"Curr. Atheroscler. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib39","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/jcb.29379","article-title":"Tackling endothelium remodeling in cardiovascular disease","volume":"121","author":"Gu\u013ea\u0161ov\u00e1","year":"2020","journal-title":"J. Cell Biochem"},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib40","doi-asserted-by":"crossref","first-page":"L91","DOI":"10.1152\/ajplung.00508.2005","article-title":"Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4","volume":"291","author":"Qiao","year":"2006","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2026.119069_bib41","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.intimp.2016.07.014","article-title":"Stearoyl lysophosphatidylcholine enhances the phagocytic ability of macrophages through the AMP-activated protein kinase\/p38 mitogen activated protein kinase pathway","volume":"39","author":"Quan","year":"2016","journal-title":"Int Immunopharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119069_bib42","doi-asserted-by":"crossref","first-page":"C1199","DOI":"10.1152\/ajpcell.00425.2022","article-title":"p38 MAPK activation and STIM1-Orai3 association mediate TRPC6 externalization","volume":"324","author":"Chaudhuri","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119069_bib43","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1161\/01.ATV.18.4.568","article-title":"Biphasic Regulation of Transcription Factor Nuclear Factor-\u03baB Activity in Human Endothelial Cells by Lysophosphatidylcholine Through Protein Kinase C\u2013Mediated Pathway","volume":"18","author":"Sugiyama","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119069_bib44","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/ATVBAHA.115.305282","article-title":"Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway","volume":"35","author":"Yin","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2026.119069_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102142","article-title":"Procaspase-1 patrolled to the nucleus of proatherogenic lipid LPC-activated human aortic endothelial cells induces ROS promoter CYP1B1 and strong inflammation","volume":"47","author":"Lu","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2026.119069_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117443","article-title":"The mechanisms of lysophosphatidylcholine in the development of diseases","volume":"247","author":"Liu","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib47","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1080\/21655979.2021.1956671","article-title":"Lysophosphatidylcholine promotes intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression in human umbilical vein endothelial cells via an orphan G protein receptor 2-mediated signaling pathway","volume":"12","author":"Zhang","year":"2021","journal-title":"Bioengineered"},{"issue":"5","key":"10.1016\/j.biopha.2026.119069_bib48","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/01.ATV.18.5.842","article-title":"Upregulation of VCAM-1 and ICAM-1 at Atherosclerosis-Prone Sites on the Endothelium in the ApoE-Deficient Mouse","volume":"18","author":"Nakashima","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2026.119069_bib49","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3389\/fphar.2020.00642","article-title":"Cellular Mechanisms of Human Atherogenesis: Focus on Chronification of Inflammation and Mitochondrial Mutations","volume":"11","author":"Markin","year":"2020","journal-title":"Front Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2026.119069_bib50","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/s41590-020-0768-4","article-title":"Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression","volume":"21","author":"Williams","year":"2020","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/XCE.0000000000000172","article-title":"Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a review","volume":"8","author":"Poston","year":"2019","journal-title":"Cardiovasc Endocrinol. Metab."},{"issue":"13","key":"10.1016\/j.biopha.2026.119069_bib52","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/cvr\/cvad130","article-title":"Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis: drug discovery and development of vascular cell adhesion molecule-1-directed novel therapeutics","volume":"119","author":"Pickett","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/j.biopha.2026.119069_bib53","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1055\/s-0039-1683409","article-title":"Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability","volume":"119","author":"Diehl","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/cvr\/cvn015","article-title":"Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis","volume":"78","author":"Siegel-Axel","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"11","key":"10.1016\/j.biopha.2026.119069_bib55","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.biocel.2010.07.012","article-title":"Platelets: pleiotropic roles in atherogenesis and atherothrombosis","volume":"42","author":"Linden","year":"2010","journal-title":"Int J. Biochem Cell Biol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119069_bib56","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1194\/jlr.E052886","article-title":"Unraveling the PAF-AH\/Lp-PLA2 controversy","volume":"55","author":"Stafforini","year":"2014","journal-title":"J. Lipid Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(93)90217-I","article-title":"Modified forms of low density lipoprotein and atherosclerosis","volume":"98","author":"Aviram","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2026.119069_bib58","first-page":"3","article-title":"A novel insight into the nature of modified low-density lipoproteins and their role in atherosclerosis","volume":"7","author":"Dmitry","year":"2023","journal-title":"Vessel"},{"key":"10.1016\/j.biopha.2026.119069_bib59","doi-asserted-by":"crossref","first-page":"29240","DOI":"10.3402\/fnr.v59.29240","article-title":"LDL biochemical modifications: a link between atherosclerosis and aging","volume":"59","author":"Alique","year":"2015","journal-title":"Food Nutr. Res"},{"key":"10.1016\/j.biopha.2026.119069_bib60","series-title":"Biochemistry, Low Density Lipoprotein, StatPearls, StatPearls Publishing Copyright \u00a9 2024","author":"Venugopal","year":"2024"},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib61","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cvr\/cvp036","article-title":"RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice","volume":"82","author":"Sun","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119069_bib62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0021-9150(91)90198-C","article-title":"Some questions concerning a small, more electronegative LDL circulating in human plasma","volume":"91","author":"Avogaro","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2026.119069_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114455","article-title":"Oxidized low-density lipoprotein induced ferroptosis in nucleus pulposus cell contributes to intervertebral disc degeneration via LOX-1\/NF-kappaB\/NOX signal","volume":"153","author":"Liu","year":"2025","journal-title":"Int Immunopharmacol."},{"issue":"13","key":"10.1016\/j.biopha.2026.119069_bib64","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1096\/fasebj.8.13.7926374","article-title":"Necrosis and apoptosis induced by oxidized low density lipoproteins occur through two calcium-dependent pathways in lymphoblastoid cells","volume":"8","author":"Escargueil-Blanc","year":"1994","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.biopha.2026.119069_bib65","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-2275(20)37262-X","article-title":"Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: effect of lysophosphatidylcholine composition on vascular relaxation","volume":"38","author":"Chen","year":"1997","journal-title":"J. Lipid Res"},{"issue":"2-3","key":"10.1016\/j.biopha.2026.119069_bib66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1388-1981(02)00343-8","article-title":"Oxidized low-density lipoprotein-induced apoptosis","volume":"1585","author":"Salvayre","year":"2002","journal-title":"Biochim Biophys. Acta"},{"issue":"3","key":"10.1016\/j.biopha.2026.119069_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030583","article-title":"Electronegative LDL Promotes Inflammation and Triglyceride Accumulation in Macrophages","volume":"9","author":"Puig","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1194\/jlr.M700305-JLR200","article-title":"Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1","volume":"49","author":"Tang","year":"2008","journal-title":"J. Lipid Res"},{"issue":"5","key":"10.1016\/j.biopha.2026.119069_bib69","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/CIRCRESAHA.108.190116","article-title":"Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis","volume":"104","author":"Lu","year":"2009","journal-title":"Circ. Res"},{"issue":"7","key":"10.1016\/j.biopha.2026.119069_bib70","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/clinchem\/41.7.1018","article-title":"Modified (desialylated) low-density lipoprotein measured in serum by lectin-sorbent assay","volume":"41","author":"Tertov","year":"1995","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib71","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/j.crvasa.2016.10.003","article-title":"Circulating desialylated low density lipoprotein","volume":"59","author":"Orekhov","year":"2017","journal-title":"Cor Et. Vasa"},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib72","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12944-016-0308-2","article-title":"Lipid composition of circulating multiple-modified low density lipoprotein","volume":"15","author":"Zakiev","year":"2016","journal-title":"Lipids Health Dis."},{"issue":"5","key":"10.1016\/j.biopha.2026.119069_bib73","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/clc.4960270503","article-title":"Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis","volume":"27","author":"Deb","year":"2004","journal-title":"Clin. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119069_bib74","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.clinbiochem.2003.12.007","article-title":"Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models","volume":"37","author":"Boffa","year":"2004","journal-title":"Clin. Biochem"},{"issue":"8","key":"10.1016\/j.biopha.2026.119069_bib75","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.115.016757","article-title":"Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic Valve","volume":"132","author":"Bouchareb","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2026.119069_bib76","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/01.ATV.3.3.215","article-title":"Lipoprotein oxidation and lipoprotein-induced cytotoxicity","volume":"3","author":"Hessler","year":"1983","journal-title":"Arteriosclerosis"},{"issue":"12","key":"10.1016\/j.biopha.2026.119069_bib77","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1161\/ATVBAHA.108.179697","article-title":"Oxidized low-density lipoprotein and atherosclerosis","volume":"30","author":"Steinberg","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2026.119069_bib78","first-page":"1","article-title":"The role and mechanism of PGC-1alpha in oxLDL-induced ferroptosis of vascular endothelial cells","volume":"61","author":"Li","year":"2025","journal-title":"Atheroscler"},{"issue":"6","key":"10.1016\/j.biopha.2026.119069_bib79","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1159\/000313879","article-title":"Oxidized low-density lipoprotein induces apoptosis in endothelial progenitor cells by inactivating the phosphoinositide 3-kinase\/Akt pathway","volume":"47","author":"Tie","year":"2010","journal-title":"J. Vasc. Res"},{"key":"10.1016\/j.biopha.2026.119069_bib80","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-1-60327-029-8_24","article-title":"Oxidized low-density lipoprotein","volume":"610","author":"Parthasarathy","year":"2010","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119069_bib81","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/01.ATV.20.10.2243","article-title":"Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease","volume":"20","author":"Toshima","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.14.1","article-title":"Measurement of plasma oxidized low-density lipoprotein and its clinical implications","volume":"14","author":"Itabe","year":"2007","journal-title":"J. Atheroscler. Thromb."},{"issue":"9","key":"10.1016\/j.biopha.2026.119069_bib83","doi-asserted-by":"crossref","first-page":"818","DOI":"10.5551\/jat.9142","article-title":"An alternative protein standard to measure activity of LOX-1 ligand containing apoB (LAB) - utilization of anti-LOX-1 single- chain antibody fused to apoB fragment","volume":"18","author":"Iwamoto","year":"2011","journal-title":"J. Atheroscler. Thromb."},{"issue":"6","key":"10.1016\/j.biopha.2026.119069_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065747","article-title":"The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation","volume":"24","author":"Itabe","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib85","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/abbi.2001.2509","article-title":"A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin","volume":"394","author":"Burkitt","year":"2001","journal-title":"Arch. Biochem Biophys."},{"issue":"7","key":"10.1016\/j.biopha.2026.119069_bib86","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.numecd.2020.03.015","article-title":"Oxidized LDL induces procoagulant profiles by increasing lysophosphatidylcholine levels, lysophosphatidylethanolamine levels, and Lp-PLA(2) activity in borderline hypercholesterolemia","volume":"30","author":"Kim","year":"2020","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib87","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0005-2760(79)90069-9","article-title":"Characterization of low density lipoprotein-like particle in the human aorta from grossly normal and atherosclerotic regions","volume":"573","author":"Hoff","year":"1979","journal-title":"Biochim Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib88","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/01.ATV.8.1.79","article-title":"Presence of a modified low density lipoprotein in humans","volume":"8","author":"Avogaro","year":"1988","journal-title":"Arteriosclerosis"},{"issue":"16","key":"10.1016\/j.biopha.2026.119069_bib89","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1161\/01.CIR.0000065220.70220.F7","article-title":"Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription","volume":"107","author":"Chen","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.biopha.2026.119069_bib90","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s11883-014-0428-y","article-title":"The underlying chemistry of electronegative LDL's atherogenicity","volume":"16","author":"Ke","year":"2014","journal-title":"Curr. Atheroscler. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30243-w","article-title":"Range of L5 LDL levels in healthy adults and L5's predictive power in patients with hyperlipidemia or coronary artery disease","volume":"8","author":"Chu","year":"2018","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.biopha.2026.119069_bib92","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1182\/blood-2013-05-504639","article-title":"Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation","volume":"122","author":"Chan","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.biopha.2026.119069_bib93","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood-2015-05-646117","article-title":"Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation","volume":"127","author":"Shen","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biopha.2026.119069_bib94","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1042\/bj1800647","article-title":"Unaltered catabolism of desialylated low-density lipoprotein in the pig and in cultured rat hepatocytes","volume":"180","author":"Attie","year":"1979","journal-title":"Biochem J."},{"issue":"5","key":"10.1016\/j.biopha.2026.119069_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051174","article-title":"Thirty-Five-Year History of Desialylated Lipoproteins Discovered by Vladimir Tertov","volume":"10","author":"Glanz","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2026.119069_bib96","first-page":"525","article-title":"LDL electronegativity index: a potential novel index for predicting cardiovascular disease","volume":"11","author":"Ivanova","year":"2015","journal-title":"Vasc. Health Risk Manag"},{"issue":"4","key":"10.1016\/j.biopha.2026.119069_bib97","first-page":"155","article-title":"Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation","volume":"14","author":"Tertov","year":"1992","journal-title":"Int J. Tissue React."},{"issue":"3","key":"10.1016\/j.biopha.2026.119069_bib98","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-0004.1974.tb00657.x","article-title":"Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease","volume":"6","author":"Berg","year":"1974","journal-title":"Clin. Genet"},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib99","first-page":"76","article-title":"Lipoprotein (a): structure, pathophysiology and clinical implications","volume":"103","author":"Maranh\u00e3o","year":"2014","journal-title":"Arq. Bras. Cardiol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119069_bib100","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","article-title":"Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups","volume":"139","author":"Par\u00e9","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.biopha.2026.119069_bib101","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jamacardio.2020.2413","article-title":"Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial","volume":"5","author":"Puri","year":"2020","journal-title":"JAMA Cardiol."},{"issue":"4932","key":"10.1016\/j.biopha.2026.119069_bib102","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.2530631","article-title":"The Mysteries Of Lipoprotein(a)","volume":"246","author":"Utermann","year":"1989","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib103","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/clinchem\/hvaa247","article-title":"Lipoprotein(a) and Cardiovascular Disease","volume":"67","author":"Kamstrup","year":"2020","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2026.119069_bib104","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1253\/circj.CJ-20-0051","article-title":"Lipoprotein(a) and Cardiovascular Diseases- Revisited","volume":"84","author":"Jang","year":"2020","journal-title":"Circ. J."},{"issue":"10","key":"10.1016\/j.biopha.2026.119069_bib105","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/rcm.6883","article-title":"Simultaneous quantitation and size characterization of apolipoprotein(a) by ultra-performance liquid chromatography\/mass spectrometry","volume":"28","author":"Lassman","year":"2014","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib106","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/0004563220968473","article-title":"Lp(a): When and how to measure it","volume":"58","author":"Cegla","year":"2021","journal-title":"Ann. Clin. Biochem"},{"key":"10.1016\/j.biopha.2026.119069_bib107","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2022.04.008","article-title":"Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?","volume":"349","author":"Kronenberg","year":"2022","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.biopha.2026.119069_bib108","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2026.119069_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100641","article-title":"Lipoprotein(a): Emerging insights and therapeutics","volume":"18","author":"Kaur","year":"2024","journal-title":"Am. J. Prev. Cardiol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119069_bib110","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1194\/jlr.M040733","article-title":"Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)","volume":"54","author":"Leibundgut","year":"2013","journal-title":"J. Lipid Res"},{"issue":"5","key":"10.1016\/j.biopha.2026.119069_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051090","article-title":"Targeted Strategy in Lipid-Lowering Therapy","volume":"10","author":"Dayar","year":"2022","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.biopha.2026.119069_bib112","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s40265-016-0613-0","article-title":"Unmet Needs in LDL-C Lowering: When Statins Won't Do!","volume":"76","author":"Kr\u00e4henb\u00fchl","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2026.119069_bib113","doi-asserted-by":"crossref","DOI":"10.46235\/1028-7221-16757-TEO","article-title":"Effect of statin administration on the inflammatory response of monocytes in patients with atherosclerosis","author":"Kirichenko","year":"2024","journal-title":"Russ. J. Immunol."},{"issue":"4a","key":"10.1016\/j.biopha.2026.119069_bib114","doi-asserted-by":"crossref","first-page":"4b","DOI":"10.1016\/S0002-9149(02)03267-8","article-title":"Mechanisms of plaque stabilization with statins","volume":"91","author":"Libby","year":"2003","journal-title":"Am. J. Cardiol."},{"issue":"21","key":"10.1016\/j.biopha.2026.119069_bib115","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.jacc.2014.08.045","article-title":"Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study","volume":"64","author":"Komukai","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119069_bib116","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.tcm.2019.01.001","article-title":"Effect of statins on atherosclerotic plaque","volume":"29","author":"Almeida","year":"2019","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib117","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib118","doi-asserted-by":"crossref","first-page":"29201","DOI":"10.1038\/s41598-024-80578-w","article-title":"Association between low-density lipoprotein cholesterol levels and all-cause mortality in patients with coronary artery disease: a real-world analysis using data from an international network","volume":"14","author":"Scudeler","year":"2024","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2026.119069_bib119","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.22558","article-title":"Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and Mortality in China","volume":"7","author":"Chen","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"42","key":"10.1016\/j.biopha.2026.119069_bib120","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1093\/eurheartj\/ehad558","article-title":"Plasma cholesterol levels in infancy: a neglected resource","volume":"44","author":"Holven","year":"2023","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib121","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1574886318666230227143627","article-title":"Statin Associated Muscular Adverse Effects","volume":"19","author":"Kammoun","year":"2024","journal-title":"Curr. Drug Saf."},{"issue":"15","key":"10.1016\/j.biopha.2026.119069_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158364","article-title":"Statins Neuromuscular Adverse Effects","volume":"23","author":"Attardo","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib123","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/157488612800492690","article-title":"Statin related memory dysfunction in a Nigerian woman: a case report","volume":"7","author":"Okeahialam","year":"2012","journal-title":"Curr. Drug Saf."},{"issue":"8","key":"10.1016\/j.biopha.2026.119069_bib124","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/jamainternmed.2015.2092","article-title":"Statin Therapy and Risk of Acute Memory Impairment","volume":"175","author":"Strom","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib125","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.bjp.0704260","article-title":"Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function","volume":"134","author":"van Heek","year":"2001","journal-title":"Br. J. Pharm."},{"issue":"15","key":"10.1016\/j.biopha.2026.119069_bib126","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1161\/01.CIR.0000034044.95911.DC","article-title":"Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans","volume":"106","author":"Sudhop","year":"2002","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.biopha.2026.119069_bib127","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbalip.2009.01.002","article-title":"Niemann\u2013Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter","volume":"1791","author":"Davis","year":"2009","journal-title":"Biochimica et Biophysica Acta (BBA) Molecular Cell Biology Lipids"},{"issue":"29","key":"10.1016\/j.biopha.2026.119069_bib128","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg3188","article-title":"Structural insights into the mechanism of human NPC1L1-mediated cholesterol uptake","volume":"7","author":"Hu","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2026.119069_bib129","first-page":"415","article-title":"Ezetimibe therapy: mechanism of action and clinical update","volume":"8","author":"Phan","year":"2012","journal-title":"Vasc. Health Risk Manag"},{"key":"10.1016\/j.biopha.2026.119069_bib130","article-title":"Cardiovascular benefits of statin plus ezetimibe combination therapy versus statin monotherapy in acute coronary syndrome: a meta-analysis of randomized controlled trials","author":"de Oliveira Almeida","year":"2024","journal-title":"Coron. Artery Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib131","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cjco.2020.09.018","article-title":"Liver Injury Associated With Ezetimibe Monotherapy","volume":"3","author":"Kanagalingam","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.biopha.2026.119069_bib132","series-title":"Endotext, MDText.com, Inc.Copyright \u00a9 2000-2024, MDText.com","article-title":"Cholesterol Lowering Drugs","author":"Feingold","year":"2000"},{"key":"10.1016\/j.biopha.2026.119069_bib133","first-page":"S26","article-title":"Medications for Lipid Control: Statins vs Newer Drugs","volume":"40","author":"McPherson","year":"2024"},{"issue":"48","key":"10.1016\/j.biopha.2026.119069_bib134","doi-asserted-by":"crossref","first-page":"50630","DOI":"10.1074\/jbc.M410077200","article-title":"Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin\/kexin type 9a in mouse liver","volume":"279","author":"Park","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2026.119069_bib135","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI2961","article-title":"Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2","volume":"101","author":"Horton","year":"1998","journal-title":"J. Clin. Invest"},{"issue":"25","key":"10.1016\/j.biopha.2026.119069_bib136","doi-asserted-by":"crossref","first-page":"18602","DOI":"10.1074\/jbc.M702027200","article-title":"Binding of proprotein convertase subtilisin\/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation","volume":"282","author":"Zhang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119069_bib137","doi-asserted-by":"crossref","DOI":"10.1177\/10742484221100107","article-title":"A Comprehensive Review of PCSK9 Inhibitors","volume":"27","author":"Coppinger","year":"2022","journal-title":"J. Cardiovasc Pharm. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib138","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_59_19","article-title":"PCSK 9 Inhibitors: A Short History and a New Era of Lipid-lowering Therapy","volume":"20","author":"Hajar","year":"2019","journal-title":"Heart Views"},{"issue":"21","key":"10.1016\/j.biopha.2026.119069_bib139","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/j.jacc.2017.10.001","article-title":"PCSK9 Inhibitors: Economics and Policy","volume":"70","author":"Hlatky","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7855","key":"10.1016\/j.biopha.2026.119069_bib140","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biopha.2026.119069_bib141","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/MOL.0000000000000334","article-title":"Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease","volume":"27","author":"Hui","year":"2016","journal-title":"Curr. Opin. Lipido"},{"issue":"3","key":"10.1016\/j.biopha.2026.119069_bib142","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jcmgh.2018.10.015","article-title":"Regulation of Chylomicron Secretion: Focus on Post-Assembly Mechanisms","volume":"7","author":"Xiao","year":"2019","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119069_bib143","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1194\/jlr.M056051","article-title":"2nd, Dietary and biliary phosphatidylcholine activates PKC\u03b6 in rat intestine","volume":"56","author":"Siddiqi","year":"2015","journal-title":"J. Lipid Res"},{"issue":"3","key":"10.1016\/j.biopha.2026.119069_bib144","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1152\/physrev.00019.2011","article-title":"Role of the gut in lipid homeostasis","volume":"92","author":"Abumrad","year":"2012","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2026.119069_bib145","article-title":"Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma","volume":"1865","author":"Buechler","year":"2020","journal-title":"Biochim Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.biopha.2026.119069_bib146","article-title":"The mechanisms of lysophosphatidylcholine in the development of diseases","author":"Liu","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib147","doi-asserted-by":"crossref","first-page":"G77","DOI":"10.1152\/ajpgi.00301.2011","article-title":"Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis","volume":"302","author":"Kakisaka","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119069_bib148","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/MPG.0000000000003418","article-title":"Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults: A Cross-Sectional Study","volume":"74","author":"Mann","year":"2022","journal-title":"J. Pedia Gastroenterol. Nutr."},{"issue":"5","key":"10.1016\/j.biopha.2026.119069_bib149","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0009-9120(02)00327-2","article-title":"An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma","volume":"35","author":"Kishimoto","year":"2002","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nm989","article-title":"Therapeutic effects of lysophosphatidylcholine in experimental sepsis","volume":"10","author":"Yan","year":"2004","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib151","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1194\/jlr.M700184-JLR200","article-title":"Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes","volume":"49","author":"Han","year":"2008","journal-title":"J. Lipid Res"},{"issue":"12","key":"10.1016\/j.biopha.2026.119069_bib152","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.numecd.2023.08.005","article-title":"Performance of nonalcoholic fatty liver fibrosis score in estimating atherosclerotic cardiovascular disease risk","volume":"33","author":"Huang","year":"2023","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"issue":"8","key":"10.1016\/j.biopha.2026.119069_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309617","article-title":"Cardiovascular risk in US adults with nonalcoholic steatohepatitis (NASH) vs. matched non-NASH controls, National Health and Nutrition Examination Survey, 2017-2020","volume":"19","author":"Woolley","year":"2024","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2026.119069_bib154","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5356","article-title":"Research progress, challenges and perspectives of phospholipids metabolism in the LXR\u2011LPCAT3 signaling pathway and its relation to NAFLD (Review)","volume":"53","author":"Wang","year":"2024","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.biopha.2026.119069_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.569144","article-title":"Lipidomics Analysis Indicates Disturbed Hepatocellular Lipid Metabolism in Reynoutria multiflora-Induced Idiosyncratic Liver Injury","volume":"11","author":"Wu","year":"2020","journal-title":"Front Pharm."},{"issue":"26","key":"10.1016\/j.biopha.2026.119069_bib156","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.3748\/wjg.v20.i26.8407","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease","volume":"20","author":"Liu","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"9 Pt B","key":"10.1016\/j.biopha.2026.119069_bib157","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"van der Veen","year":"2017","journal-title":"Biochim Biophys. Acta Biomembr."},{"issue":"6","key":"10.1016\/j.biopha.2026.119069_bib158","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/ATVBAHA.112.249854","article-title":"Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation","volume":"32","author":"Goncalves","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119069_bib159","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1161\/ATVBAHA.115.306964","article-title":"Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation","volume":"36","author":"Li","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2026.119069_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118569","article-title":"Phospholipid-derived lysophospholipids in (patho)physiology","author":"Prabutzki","year":"2024","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.biopha.2026.119069_bib161","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/ckj\/sfab194","article-title":"Albumin is an interface between blood plasma and cell membrane, and not just a sponge","volume":"15","author":"van de Wouw","year":"2022","journal-title":"Clin. Kidney J."},{"issue":"Pt 1","key":"10.1016\/j.biopha.2026.119069_bib162","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/bj3450061","article-title":"Characterization of plasma unsaturated lysophosphatidylcholines in human and rat","volume":"345","author":"Croset","year":"2000","journal-title":"Biochem J."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib163","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.atherosclerosis.2012.06.010","article-title":"Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS\/MS","volume":"224","author":"St\u00fcbiger","year":"2012","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.biopha.2026.119069_bib164","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1194\/jlr.M014787","article-title":"Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance","volume":"52","author":"Han","year":"2011","journal-title":"J. Lipid Res"},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib165","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.atherosclerosis.2007.02.012","article-title":"Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment","volume":"196","author":"Iwase","year":"2008","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.biopha.2026.119069_bib166","article-title":"Lysophosphatidylcholine Impairs the Mitochondria Homeostasis Leading to Trophoblast Dysfunction in Gestational Diabetes Mellitus","volume":"13","author":"Hung","year":"2024","journal-title":"Antioxid. (Basel)"},{"issue":"4","key":"10.1016\/j.biopha.2026.119069_bib167","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1194\/jlr.M200401-JLR200","article-title":"Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients","volume":"44","author":"Drobnik","year":"2003","journal-title":"J. Lipid Res"},{"issue":"874","key":"10.1016\/j.biopha.2026.119069_bib168","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/pgmj.74.874.468","article-title":"Intracoronary ultrasound","volume":"74","author":"Hammond","year":"1998","journal-title":"Postgrad. Med. J."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib169","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/bmb\/ldx049","article-title":"Utility of intracoronary imaging in the cardiac catheterization laboratory: comprehensive evaluation with intravascular ultrasound and optical coherence tomography","volume":"125","author":"Parviz","year":"2018","journal-title":"Br. Med. Bull."},{"issue":"1","key":"10.1016\/j.biopha.2026.119069_bib170","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF02535301","article-title":"Lysophosphatidylcholine accumulation in the ischemic canine heart","volume":"23","author":"Kinnaird","year":"1988","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.biopha.2026.119069_bib171","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1536\/ihj.51.129","article-title":"Imaging of Lysophosphatidylcholine in Human Coronary Plaques by Color Fluorescence Angioscopy","volume":"51","author":"Uchida","year":"2010","journal-title":"Int. Heart J."},{"issue":"8","key":"10.1016\/j.biopha.2026.119069_bib172","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27082487","article-title":"Current Knowledge on Mammalian Phospholipase A(1), Brief History, Structures, Biochemical and Pathophysiological Roles","volume":"27","author":"Yaginuma","year":"2022","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.biopha.2026.119069_bib173","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4112","article-title":"Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer","volume":"32","author":"Sonkar","year":"2019","journal-title":"NMR Biomed."},{"issue":"3","key":"10.1016\/j.biopha.2026.119069_bib174","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/BJ20080165","article-title":"Mfsd2a encodes a novel major facilitator superfamily domain-containing protein highly induced in brown adipose tissue during fasting and adaptive thermogenesis","volume":"416","author":"Angers","year":"2008","journal-title":"Biochem J."},{"issue":"7501","key":"10.1016\/j.biopha.2026.119069_bib175","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13241","article-title":"Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid","volume":"509","author":"Nguyen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119069_bib176","series-title":"Biochemistry of Platelet Activating Factor, StatPearls, StatPearls Publishing. Copyright \u00a9 2024","author":"Ashraf","year":"2024"},{"issue":"10","key":"10.1016\/j.biopha.2026.119069_bib177","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/cr200085w","article-title":"Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention","volume":"111","author":"Dennis","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2026.119069_bib178","series-title":"Kelley and Firestein's Textbook of Rheumatology (Tenth Edition)","first-page":"366","article-title":"Chapter 24 - Prostaglandins, Leukotrienes, and Related Compounds","author":"Zurier","year":"2017"},{"issue":"9","key":"10.1016\/j.biopha.2026.119069_bib179","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1194\/jlr.R045492","article-title":"To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase","volume":"55","author":"Marathe","year":"2014","journal-title":"J. Lipid Res"},{"issue":"7","key":"10.1016\/j.biopha.2026.119069_bib180","article-title":"A boost for GSK's first-in-class heart drug?","volume":"9","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.biopha.2026.119069_bib181","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.2014.11061","article-title":"Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome: The SOLID-TIMI 52 Randomized Clinical Trial","volume":"312","author":"O\u2019Donoghue","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2026.119069_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118569","article-title":"Phospholipid-derived lysophospholipids in (patho)physiology","volume":"398","author":"Prabutzki","year":"2024","journal-title":"Atherosclerosis"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:31:03Z","timestamp":1774614663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":182,"alternative-id":["S0753332226001010"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119069","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysophosphatidylcholine as a mechanistic and therapeutic nexus in atherosclerotic cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119069"}}